Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 …

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199207.

Article CAS PubMed PubMed Central Google Scholar

Collaborators. GD: Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 19502021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet 2024, 403(10440):19892056.

Coronavirus disease (COVID-19) situation reports [https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports]

Carabelli AM, Peacock TP, Thorne LG, Harvey WT, Hughes J, Peacock SJ, Barclay WS, de Silva TI, Towers GJ, Robertson DL. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat Rev Microbiol. 2023;21(3):16277.

CAS PubMed PubMed Central Google Scholar

Duan Y, Zhou H, Liu X, Iketani S, Lin M, Zhang X, Bian Q, Wang H, Sun H, Hong SJ, et al. Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir. Nature. 2023;622(7982):37682.

Article CAS PubMed Google Scholar

Zuo W, He D, Liang C, Du S, Hua Z, Nie Q, Zhou X, Yang M, Tan H, Xu J, et al. The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China. Lancet Infect Dis. 2024;24(8):84555.

Article CAS PubMed Google Scholar

Cai C, Li Y, Hu T, Liang R, Wang K, Guo C, Li Y, Zhang M, Kang M. The associated factors of SARS-CoV-2 reinfection by omicron variantGuangdong Province, China, December 2022 to January 2023. China CDC Wkly. 2023;5(18):3916.

Article PubMed PubMed Central Google Scholar

Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):47581.

Article CAS PubMed PubMed Central Google Scholar

Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):78293.

Article CAS PubMed Google Scholar

Peluso MJ, Deeks SG. Mechanisms of long COVID and the path toward therapeutics. Cell. 2024;187(20):550029.

Article CAS PubMed Google Scholar

Greenhalgh T, Sivan M, Perlowski A, Nikolich J. Long COVID: a clinical update. Lancet. 2024;404(10453):70724.

Article CAS PubMed Google Scholar

Al-Aly Z, Davis H, McCorkell L, Soares L, Wulf-Hanson S, Iwasaki A, Topol EJ. Long COVID science, research and policy. Nat Med. 2024;30(8):214864.

Article CAS PubMed Google Scholar

Hampshire A, Azor A, Atchison C, Trender W, Hellyer PJ, Giunchiglia V, Husain M, Cooke GS, Cooper E, Lound A, et al. Cognition and memory after Covid-19 in a large community sample. N Engl J Med. 2024;390(9):80618.

Article CAS PubMed PubMed Central Google Scholar

Hoang DM, Pham PT, Bach TQ, Ngo ATL, Nguyen QT, Phan TTK, Nguyen GH, Le PTT, Hoang VT, Forsyth NR, et al. Stem cell-based therapy for human diseases. Signal Transduct Target Ther. 2022;7(1):272.

Article PubMed PubMed Central Google Scholar

Shi L, Wang L, Xu R, Zhang C, Xie Y, Liu K, Li T, Hu W, Zhen C, Wang FS. Mesenchymal stem cell therapy for severe COVID-19. Signal Transduct Target Ther. 2021;6(1):339.

Article CAS PubMed PubMed Central Google Scholar

Valiukeviius P, Maiulaitis J, Pangonyt D, Sirataviit V, Kluszczyska K, Kuzaityt U, Insodait R, iapien I, Grigaleviit R, Zigmantait V, et al. Human placental mesenchymal stem cells and derived extracellular vesicles ameliorate lung injury in acute respiratory distress syndrome murine model. Cells. 2023;12(23):2729.

Article PubMed PubMed Central Google Scholar

Meng M, Zhang WW, Chen SF, Wang DR, Zhou CH. Therapeutic utility of human umbilical cord-derived mesenchymal stem cells-based approaches in pulmonary diseases: recent advancements and prospects. World J Stem Cells. 2024;16(2):7088.

Article PubMed PubMed Central Google Scholar

Leng Z, Zhu R, Hou W, Feng Y, Yang Y, Han Q, Shan G, Meng F, Du D, Wang S, et al. Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. Aging Dis. 2020;11(2):21628.

Article PubMed PubMed Central Google Scholar

Lanzoni G, Linetsky E, Correa D, Messinger Cayetano S, Alvarez RA, Kouroupis D, Alvarez Gil A, Poggioli R, Ruiz P, Marttos AC, et al. Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: a double-blind, phase 1/2a, randomized controlled trial. Stem Cells Transl Med. 2021;10(5):66073.

Article CAS PubMed PubMed Central Google Scholar

Gorman EA, Rynne J, Gardiner HJ, Rostron AJ, Bannard-Smith J, Bentley AM, Brealey D, Campbell C, Curley G, Clarke M, et al. Repair of acute respiratory distress syndrome in COVID-19 by stromal cells (REALIST-COVID Trial): a multicenter, randomized, controlled clinical trial. Am J Respir Crit Care Med. 2023;208(3):25669.

Article CAS PubMed Google Scholar

Bowdish ME, Barkauskas CE, Overbey JR, Gottlieb RL, Osman K, Duggal A, Marks ME, Hupf J, Fernandes E, Leshnower BG, et al. A randomized trial of mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome from COVID-19. Am J Respir Crit Care Med. 2023;207(3):26170.

Article CAS PubMed Google Scholar

Shi L, Huang H, Lu X, Yan X, Jiang X, Xu R, Wang S, Zhang C, Yuan X, Xu Z, et al. Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial. Signal Transduct Target Ther. 2021;6(1):58.

Article CAS PubMed PubMed Central Google Scholar

Shi L, Yuan X, Yao W, Wang S, Zhang C, Zhang B, Song J, Huang L, Xu Z, Fu JL, et al. Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial. EBioMedicine. 2022;75: 103789.

Article CAS PubMed Google Scholar

Li TT, Zhang B, Fang H, Shi M, Yao WQ, Li Y, Zhang C, Song J, Huang L, Xu Z, et al. Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trial. EBioMedicine. 2023;92: 104600.

Article PubMed PubMed Central Google Scholar

Pan F, Ye T, Sun P, Gui S, Liang B, Li L, Zheng D, Wang J, Hesketh RL, Yang L, et al. Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology. 2020;295(3):71521.

Article PubMed Google Scholar

Francone M, Iafrate F, Masci GM, Coco S, Cilia F, Manganaro L, Panebianco V, Andreoli C, Colaiacomo MC, Zingaropoli MA, et al. Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis. Eur Radiol. 2020;30(12):680817.

Article CAS PubMed PubMed Central Google Scholar

Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo L, Liu M, Zhou X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):22032.

Article CAS PubMed PubMed Central Google Scholar

Laboratories ACoPSfCPF: ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002, 166(1):111117.

Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998;158(5 Pt 1):13847.

Article CAS PubMed Google Scholar

Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q, Ni F, Fang S, Lu Y, Ding X, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med. 2021;9(7):74754.

Article CAS PubMed PubMed Central Google Scholar

Ware JE Jr. SF-36 health survey update. Spine (Phila Pa 1976). 2000;25(24):31309.

Article PubMed Google Scholar

Rajala K, Lehto JT, Sutinen E, Kautiainen H, Myllrniemi M, Saarto T. mMRC dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis. ERJ Open Res. 2017;3(4):000842017.

Article PubMed PubMed Central Google Scholar

Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the medical research council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):5816.

Article CAS PubMed PubMed Central Google Scholar

Pan F, Yang L, Liang B, Ye T, Li L, Li L, Liu D, Wang J, Hesketh RL, Zheng C. Chest CT patterns from diagnosis to 1 year of follow-up in patients with COVID-19. Radiology. 2022;302(3):70919.

Article PubMed Google Scholar

Lalwani M, Taksande AB. Pulmonary function test as a diagnostic tool for post-COVID-19 effects. Cureus. 2023;15(2): e34751.

PubMed PubMed Central Google Scholar

Hastie CE, Lowe DJ, McAuley A, Mills NL, Winter AJ, Black C, Scott JT, ODonnell CA, Blane DN, Browne S, et al. Natural history of long-COVID in a nationwide, population cohort study. Nat Commun. 2023;14(1):3504.

Article CAS PubMed PubMed Central Google Scholar

Vij R, Kim H, Park H, Cheng T, Lotfi D, Chang D. Adipose-derived, autologous mesenchymal stem cell therapy for patients with post-COVID-19 syndrome: an intermediate-size expanded access program. Stem Cell Res Ther. 2023;14(1):287.

Article CAS PubMed PubMed Central Google Scholar

Wang Y, Fang J, Liu B, Shao C, Shi Y. Reciprocal regulation of mesenchymal stem cells and immune responses. Cell Stem Cell. 2022;29(11):151530.

Article CAS PubMed Google Scholar

Zhang H, Huang C, Gu X, Wang Y, Li X, Liu M, Wang Q, Xu J, Wang Y, Dai H, et al. 3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B11529) wave in 2022 in China: a longitudinal cohort study. Lancet Respir Med. 2024;12(1):5566.

Article PubMed Google Scholar

Lim JT, Liang En W, Tay AT, Pang D, Chiew CJ, Ong B, Lye DCB, Tan KB. Long-term cardiovascular, cerebrovascular, and other thrombotic complications in COVID-19 survivors: a retrospective cohort study. Clin Infect Dis. 2024;78(1):709.

Article PubMed Google Scholar

Yu W, Guo Y, Hu T, Liu Y, Fan Q, Guo L, Zheng B, Kong Y, Zhu H, Yu J, et al. Incidence and severity of SARS-CoV-2 reinfection, a multicenter cohort study in Shanghai, China. J Med Virol. 2023;95(8): e28997.

Article CAS PubMed Google Scholar

Team C-F. Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis. Lancet. 2023;401(10379):83342.

Article Google Scholar

Read more:

Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 ...